| Product Code: ETC7647616 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cell And Gene Therapy CDMO Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cell And Gene Therapy CDMO Market - Industry Life Cycle |
3.4 Israel Cell And Gene Therapy CDMO Market - Porter's Five Forces |
3.5 Israel Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Israel Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Israel Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Israel Cell And Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the field of cell and gene therapy in Israel |
4.2.2 Growing adoption of personalized medicine and targeted therapies |
4.2.3 Favorable regulatory environment for cell and gene therapy products in Israel |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy development and manufacturing |
4.3.2 Limited availability of skilled workforce and expertise in cell and gene therapy manufacturing |
4.3.3 Strict regulatory requirements and quality standards for cell and gene therapy products |
5 Israel Cell And Gene Therapy CDMO Market Trends |
6 Israel Cell And Gene Therapy CDMO Market, By Types |
6.1 Israel Cell And Gene Therapy CDMO Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F |
6.1.4 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.2 Israel Cell And Gene Therapy CDMO Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.3 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F |
6.2.4 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3 Israel Cell And Gene Therapy CDMO Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.4 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F |
6.3.5 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.3.6 Israel Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Cell And Gene Therapy CDMO Market Import-Export Trade Statistics |
7.1 Israel Cell And Gene Therapy CDMO Market Export to Major Countries |
7.2 Israel Cell And Gene Therapy CDMO Market Imports from Major Countries |
8 Israel Cell And Gene Therapy CDMO Market Key Performance Indicators |
8.1 Number of new cell and gene therapy clinical trials initiated in Israel |
8.2 Percentage of cell and gene therapy products successfully reaching commercialization stage |
8.3 Investment in infrastructure and technology upgrades in Israel's cell and gene therapy CDMO sector |
9 Israel Cell And Gene Therapy CDMO Market - Opportunity Assessment |
9.1 Israel Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Israel Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Israel Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Israel Cell And Gene Therapy CDMO Market - Competitive Landscape |
10.1 Israel Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024 |
10.2 Israel Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here